Articulo
Hypoxia in high glucose followed by reoxygenation in normal glucose reduces the viability of cortical astrocytes through increased permeability of connexin 43 hemichannels
GLIA;
Glia
Registro en:
0
D07I1086
D07I1086
WOS:000273189600007
0894-1491
Autor
Velarde-Aliaga, María
Saez-Carreño, Juan
Bennet, Michael
Ezan, Pascal
Giaume, Christian
Hernández, Diego
Orellana, Juan
Institución
Resumen
Brain ischemia causes more extensive injury in hyperglycemic than normoglycemic subjects, and the increased damage is to astroglia as well as neurons. In the present work, we found that in cortical astrocytes from rat or mouse, reoxygenation after hypoxia in a medium mimicking interstitial fluid during ischemia increases hemichannel activity and decreases cell-cell communication via gap junctions as indicated by dye uptake and dye coupling, respectively. These effects were potentiated by high glucose during the hypoxia in a concentration-dependent manner (and by zero glucose) and were not observed in connexin 43(-/-) astrocytes. The responses were transient and persistent after short and long periods of hypoxia, respectively. The persistent responses were associated with a progressive reduction in cell viability that was prevented by La(3+) or peptides that block connexin 43 (Cx43) hemichannels or by inhibition of p38 MAP kinase prior to hypoxia-reoxygenation but not by treatments that block pannexin hemichannels. Block of Cx43 hemichannels did not affect the reduction in gap junction mediated dye coupling observed during reoxygenation. Cx43 hemichannels may be a novel therapeutic target to reduce cell death following stroke, particularly in hyperglycemic conditions. (C) 2009 Wiley-Liss, Inc. CONICYT; Grant number: 24080055 (to J.A.O.); Grant sponsor: FONDECYT; Grant number: 1070591 (to J.C.S.); Grant sponsor: FONDEF; Grant number: D0711086 (to J.C.S.); Grant sponsor: NIH; Grant numbers: NS37402, NS45287 (to M.V.L.B.); Grant sponsor: INSERM/CONICYT (to C.G. and J.C.S.). 66 FONDEF jaorella@uc.cl CONICYT [24080055]; FONDECYT [1070591]; FONDEF [D0711086]; NIH [NS37402, NS45287]; INSERM/CONICYT 3 FONDEF 58